Guardant Health
GH
#1093
Rank
C$31.62 B
Marketcap
C$238.50
Share price
-1.63%
Change (1 day)
253.91%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): C-$4.67

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is C-$4.81. In 2025 the company made an earnings per share (EPS) of C-$4.70 an increase over its 2024 EPS that were of C-$5.05.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$4.67-0.63%
2025C-$4.70-7.02%
2024C-$5.05-16.82%
2023C-$6.08-33.13%
2022C-$9.0960%
2021C-$5.6855.04%
2020C-$3.66207.14%
2019C-$1.19-19.81%
2018C-$1.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
C-$3.98-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C-$3.52-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA